Zephyrnet Logo

Tag: Breast cancer

Time to look Beyond Compulsory Licenses? A Glimpse at the Ribociclib Case

. Recently, the Print reported that Novartis and Eli Lilly have voiced their opposition to the idea of compulsory licensing (“CL”) for breast cancer medications,...

High-quality diagnostic imaging – for all skin tones – Physics World

Photoacoustic (PA) imaging is a non-invasive diagnostic technique that can visualize anatomic structures – such as arteries and blood vessels –...

The Cannabis Cancer Connection | Project CBD

Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. Goldstrich, MD, with Angela Bacca (Flower...

Proton therapy on an upward trajectory while FLASH treatment schemes get ready to shine – Physics World

Innovation in proton therapy was front-and-centre at the ASTRO Annual Meeting, along with advances in other cutting-edge modalities – among them...

Leukemia & Hemp Derived CBD

CANCER x STATS Cancer has become a major public health concern in the United States and around the globe. It is estimated that one in...

Ninth Annual Penske Pink Out Drives Breast Cancer Awareness

Penske associates across the organization will join today for Penske Pink Out – an associate-led breast cancer awareness event now in its ninth year.Associates...

The Impact Of Smart Technology On Healthcare – IoTWorm

Smart technology is when devices use the internet, artificial intelligence (AI), the cloud and other modern functionalities. A smart city aims to promote economic...

Cancer-Killing Duo Hunts Down and Destroys Tumors With Surprising Alacrity

Bacteria may seem like a strange ally in the battle against cancer.But in a new study, genetically engineered bacteria were part of a tag-team...

SpicyIP Weekly Review (September 25- October 1)

Wondering what IP developments took place last week? Look no further as we present to you the SpicyIP Weekly Review, highlighting the discussions that...

CIRM invests nearly $44 million to advance regenerative medicine research and manufacturing in California

September 29, 2023 South San Francisco, CA –  The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine,...

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III...

A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...

Hologic and Bayer partner to expand breast cancer detection

The two companies are working together on contrast-enhanced mammography According to the World Health Organization, there were 2.3 million women diagnosed with...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?